- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
AMPY
NYSE
Week ended 31 Jul 2026
Weekly Investor Report
Amplify Energy Corp · Energy · Oil & Gas E&P
Latest close
3.91 USD
-0.8%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -23.3% below the Trend Line and sits at 14.8% of its 52-week range. The latest completed week returned -0.8%, after a -2.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is bullish with 43/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.
Setup score
26
out of 100
Latest Close
3.91 USD
31 Jul 2026
1W Return
-0.8%
latest completed week
4W Return
-2.2%
short-term follow-through
12W Return
-26.1%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.8%
Latest completed week; four-week move -2.2%.
Indicator stack
38/27
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Options pressure
Bullish
43/100 conviction; expected move 15.2%.
News sentiment
52/100
67 relevant articles in the latest sentiment read.
Event risk
4d
Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -23.3% below the Trend Line and sits at 14.8% of its 52-week range. The latest completed week returned -0.8%, after a -2.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0512-week average 0.42
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.2% over four weeks, -26.1% over 12 weeks, and 7.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.28Latest activity-pressure read.
Pressure change-3.8%Four-week change in activity pressure.
Leadership-27.46Latest relative-leadership reading.
RS change-6.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 97%
Model confidence 93%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength89/100Blend of value, momentum, and quality. Underlying universe rank 12; rank 1 is best.
Value98/100Relative valuation strength. Underlying universe rank 3; rank 1 is best.
Quality69/100Profitability and accounting quality. Underlying universe rank 32; rank 1 is best.
Momentum31/100Medium-term price momentum. Underlying universe rank 70; rank 1 is best.
Growth4/100Revenue and earnings growth. Underlying universe rank 97; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 13.9x Price divided by trailing earnings.
- Price / sales
- 0.7x Market value relative to trailing revenue.
- EV / EBITDA
- 1.9x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 86.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 44.7% Gross profit retained from each unit of revenue.
- Operating margin
- 13.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 46.9% Free cash flow generated from revenue.
- Return on invested capital
- 5.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -99.7% Latest one-year revenue growth.
- EPS growth
- -28.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -26.7% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
AMPY shows bullish options pressure with a 43/100 conviction score, put-call volume ratio of 0.34, expected move of 15.2%, and Sharemaestro trend signal inactive.
Conviction43/100
Expected move15.2%
Put/call volume0.34
Insider activity9 / 4
9 acquisitions and 4 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment52/100
Weighted news tone is neutral across 67 relevant articles.
11 positive · 48 neutral · 8 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings4dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move15.2%Nearest-chain priced movement where available.
52-week drawdown-42.4%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher11 of 2613 weeks finished lower.
Best week+10.4%Week of 24 Apr.
Worst week-14.8%Week of 8 May.
Latest week-0.8%Week of 31 Jul.
Shape of recent returns
Strong gains6
Modest gains5
Flat weeks2
Modest losses5
Sharp losses8
Recent vol4.2%13-week weekly-return volatility.
Base vol8.8%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew7.5% / -5.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Energy
4-week rank- / 100
Group average9.6%
Trend breadth67.0%
Trend67.0%active weekly trend signals
MD19.0%positive activity pressure
RS77.0%positive relative leadership
Four-week leaders
IndustryUS Oil & Gas E&P
4-week rank54 / 61
Group average8.6%
Trend breadth42.6%
Trend42.6%active weekly trend signals
MD6.6%positive activity pressure
RS54.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.05; No reversal markers Factors72/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 24; Buyback Yield rank 62; Small Cap Core rank 10 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options45/100AMPY shows bullish options pressure with a 43/100 conviction score, put-call volume ratio of 0.34, expected move of 15.2%, and Sharemaestro trend signal inactive.
Bullish · Call-side pressure · Expected move 15.2% Sentiment52/100Weighted news tone is neutral across 67 relevant articles.
European earnings growth estimate rises to 20.8% as energy profits surge Insiders9 / 49 acquisitions and 4 disposals in the latest 180-day insider tape.
Earnings4dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 3.91 USD | -0.8% | 5.10 USD | 5.49 USD | -1.28 | -27.46 | 2.7M | Off |
| 24 Jul 2026 | 3.94 USD | 0.0% | 5.12 USD | 5.51 USD | -1.28 | -26.24 | 3.4M | Off |
| 17 Jul 2026 | 3.94 USD | 0.0% | 5.14 USD | 5.53 USD | -1.23 | -26.80 | 2.7M | Off |
| 10 Jul 2026 | 3.94 USD | -1.5% | 5.17 USD | 5.55 USD | -1.22 | -27.92 | 3.5M | Off |
| 3 Jul 2026 | 4.00 USD | 1.5% | 5.20 USD | 5.56 USD | -1.23 | -25.87 | 2.5M | Off |
| 26 Jun 2026 | 3.94 USD | -4.6% | 5.25 USD | 5.58 USD | -1.21 | -25.38 | 9.5M | Off |
| 19 Jun 2026 | 4.13 USD | -4.8% | 5.30 USD | 5.60 USD | -1.33 | -23.66 | 2.9M | Off |
| 12 Jun 2026 | 4.34 USD | -0.7% | 5.34 USD | 5.62 USD | -1.28 | -19.18 | 3.2M | Off |
| 5 Jun 2026 | 4.37 USD | -5.6% | 5.39 USD | 5.63 USD | -1.15 | -18.20 | 3.5M | Off |
| 29 May 2026 | 4.63 USD | -7.6% | 5.42 USD | 5.65 USD | -1.01 | -15.40 | 2.7M | Off |
| 22 May 2026 | 5.01 USD | -4.2% | 5.42 USD | 5.66 USD | -0.65 | -6.83 | 3.0M | Off |
| 15 May 2026 | 5.23 USD | -1.1% | 5.41 USD | 5.68 USD | -0.37 | -1.36 | 4.7M | On |
| 8 May 2026 | 5.29 USD | -14.8% | 5.38 USD | 5.69 USD | -0.21 | 0.55 | 3.7M | On |
| 1 May 2026 | 6.21 USD | 6.3% | 5.36 USD | 5.70 USD | 0.17 | 21.47 | 2.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.